Clinical Trials Directory

Trials / Completed

CompletedNCT06751550

Changes in FeNO Value During Pulmonary Rehabilitation in Patients with Asthma

Change in Daily FeNO During Three Weeks of Inpatient Pulmonary Rehabilitation in Patients with Asthma

Status
Completed
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Schön Klinik Berchtesgadener Land · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigates the use of fractional exhaled nitric oxide (FeNO) measurement to monitor non-pharmacological therapy during a three-week inpatient rehabilitation programme for asthma patients. It compares FeNO levels (measured three times a day) with clinical parameters and quality of life to analyse daily fluctuations and the acute effect of exercise training on FeNO levels. As FeNO is a non-invasive biomarker of airway inflammation, this study aims to expand its role in therapy monitoring and explore its application in a rehabilitation setting.

Conditions

Timeline

Start date
2021-05-17
Primary completion
2024-12-20
Completion
2024-12-20
First posted
2024-12-30
Last updated
2025-01-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06751550. Inclusion in this directory is not an endorsement.

Changes in FeNO Value During Pulmonary Rehabilitation in Patients with Asthma (NCT06751550) · Clinical Trials Directory